Synonyms:altretamine, 645-05-6, HEXAMETHYLMELAMINE, Hexalen, Hexastat, Hemel, 2,4,6-Tris(dimethylamino)-1,3,5-triazine, N2,N2,N4,N4,N6,N6-hexamethyl-1,3,5-triazine-2,4,6-triamine, Melamine, hexamethyl-, Altretaminum, Altretamina, Altretaminum [INN-Latin], ENT 50852, NC 195, 2,4,6-Tris(dimethylamino)-s-triazine, NCI-C50259, HMM, Altretamine (Hexalen), NSC 13875, HTM, HXM, 2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine, s-Triazine, 2,4,6-tris(dimethylamino)-, 1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N'',N''-hexamethyl-, NSC-13875, MLS000069621, N,N,N',N',N'',N''-hexamethyl-1,3,5-triazine-2,4,6-triamine, NSC13875, Q8BIH59O7H, SMR000058181, 645-05-6 (free base), DTXSID4022579, CHEBI:24564, NCGC00015100-02, ENT-50852;RB-1515;WR-95704, Altretamina [INN-Spanish], DTXCID902579, CAS-645-05-6, Hexalen (TN), CCRIS 5492, SR-01000000117, Hexalen [Antineoplastic], Altretamine (USP/INN), EINECS 211-428-4, UNII-Q8BIH59O7H, BRN 0195058, AI3-50852, HSDB 7559, Altretamine, solid, Altretamine [USAN:USP:INN:BAN], KB-913, Spectrum_001308, ALTRETAMINE [MI], Opera_ID_1095, Prestwick0_000946, Prestwick1_000946, Prestwick2_000946, Prestwick3_000946, Spectrum2_000907, Spectrum3_000951, Spectrum4_001064, Spectrum5_001092, ALTRETAMINE [INN], Lopac-A-8723, ChemDiv2_005185, ALTRETAMINE [HSDB], ALTRETAMINE [USAN], 2,4, 6-Tris(dimethylamino)-1,3,5-triazine, A 8723, ALTRETAMINE [VANDF], Cambridge id 5148727, cid_2123, SCHEMBL4206, ALTRETAMINE [MART.], CHEMBL1455, Lopac0_000083, ALTRETAMINE [USP-RS], ALTRETAMINE [WHO-DD], BSPBio_000912, KBioGR_001388, KBioSS_001788, MLS001076123, DivK1c_000772, SPECTRUM1503065, SPBio_000754, SPBio_003071, BPBio1_001004, GTPL7112, BDBM37631, HMS502G14, KBio1_000772, KBio2_001788, KBio2_004356, KBio2_006924, KBio3_002042, ALTRETAMINE [ORANGE BOOK], NINDS_000772, BCPP000413, HMS1383L15, HMS1570N14, HMS1922C05, HMS2090G17, HMS2092H16, HMS2097N14, HMS2234F09, HMS3259I20, HMS3260A08, HMS3372H17, HMS3654H11, HMS3714N14, Pharmakon1600-01503065, ALTRETAMINE [USP MONOGRAPH], 1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N',N'-hexamethyl-, BCP27675, CCG-2238, HY-B0181, 2,6-Tris(dimethylamino)-s-triazine, Tox21_110085, Tox21_202784, Tox21_500083, ENT-50852, MFCD00549245, NSC758231, s1278, STK749184, s-Triazine,4,6-tris(dimethylamino)-, AKOS001729401, Tox21_110085_1, 1,3,5-Tris(dimethylamino)-s-triazine, BCP9000278, CS-2061, DB00488, KS-5247, LP00083, NC00595, NSC-758231, RB-1515, SB73671, SDCCGSBI-0050071.P004, IDI1_000772, IDI1_003900, N~2~,N~2~,N~4~,N~4~,N~6~,N~6~-Hexamethyl-1,3,5-triazine-2,4,6-triamine, NCGC00015100-01, NCGC00015100-03, NCGC00015100-04, NCGC00015100-05, NCGC00015100-06, NCGC00015100-07, NCGC00015100-08, NCGC00015100-09, NCGC00015100-10, NCGC00015100-11, NCGC00015100-12, NCGC00015100-14, NCGC00015100-15, NCGC00015100-23, NCGC00021216-03, NCGC00021216-04, NCGC00021216-05, NCGC00021216-06, NCGC00021216-07, NCGC00260330-01, NCGC00260768-01, AC-12006, CAS-654-05-6, NCI60_000871, WR-95704, 2,6-Tris(dimethylamino)-1,3,5-triazine, SBI-0050071.P003, DB-054676, AB00052308, EU-0100083, FT-0651499, SW102053-5, C76020, D02841, EN300-122382, AB00052308-16, AB00052308-17, AB00052308-18, AB00052308_19, AB00052308_20, A834788, Q415242, WLN: T6N CN ENJ BN1&1 DN1&1 FN1&1, 2,4,6-Tris(dimethylamino)-1,3,5-triazine, 96%, J-523408, SR-01000000117-2, SR-01000000117-4, SR-01000000117-6, BRD-K67043667-001-04-1, BRD-K67043667-001-15-7, Z57931197, N2,N2,N4,N4,N6,N6-Hexamethyl-1,3,5-trazne-2,4,6-tramne, 1,5-Triazine-2,4,6-triamine, N,N,N',N',N'',N''-hexamethyl-, Altretamine, United States Pharmacopeia (USP) Reference Standard, N-[4,6-bis(dimethylamino)-1,3,5-triazin-2-yl]-N,N-dimethylamine, 1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N'', N''-hexamethyl-
Pubchem:PUBCHEM:2123
Id:272d3f45-17ed-54ba-8a4e-5158820eeee7
Description:nan
